← Leaderboards
Julie L Eiseman
Boston University
$2,689,914
Attributed
$2,689,914
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $489.1K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,689,914 · 3
By mechanism
N01$1,665,767 · 1
P01$1,024,147 · 1
U54$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University
Same institution · by research overlap
- James S. Panek$3,553,740
- Stephen G Bown$0
- Laurence Lovat$0
- Roberto Reif$75,702
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesPlasmaScheduleDrug KineticsBiologicalAnalytical MethodMetabolic Abnormality AssessmentRouteTumorInvestigationResearch PersonnelPeer ReviewPharmacologic SubstancePharmacodynamicsAnimalsMolecularOralPharmacologyIntravenousIn VitroDesignDrug Or Chemical Tissue DistributionBaseIn Vivo
Grant awards (12)
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$394,815
N01 · FY2016 · CA · contact PI
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$76,841
N01 · FY2015 · CA · contact PI
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$228,432
N01 · FY2014 · CA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$489,053
N01 · FY2013 · CA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$426,626
N01 · FY2012 · CA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$50,000
N01 · FY2011 · CA · contact PI
Preclinical Evaluation:Tubulin Binding Agent & Dual Spec. Phosphatase Inhibitors$265,624
P01 · FY2009 · CA · contact PI
Preclinical Evaluation:Tubulin Binding Agent & Dual Spec. Phosphatase Inhibitors$242,278
P01 · FY2008 · CA · contact PI
Preclinical Evaluation:Tubulin Binding Agent & Dual Spec. Phosphatase Inhibitors$224,843
P01 · FY2007 · CA · contact PI
PRECLINICAL EVAL. OF TUBULIN BINDING AGENTS AND DUAL SPEC. PHOSP INHIB. IN RODENT$147,855
P01 · FY2006 · CA · contact PI
PRECLINICAL EVAL. OF TUBULIN BINDING AGENTS AND DUAL SPEC. PHOSP INHIB. IN RODENT$143,547
P01 · FY2005 · CA
Noninvasive OP of lutetium and gadolinium texaphyrins and Pc4$0
U54 · FY2003 · CA